111 – 120 of 555
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
- Contribution to journal › Article
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
- Contribution to journal › Article
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
- Contribution to journal › Article
-
Mark
Recurrence pattern in localized RCC : results from a European multicenter database (RECUR)
- Contribution to journal › Article
-
Mark
Community-onset urosepsis : incidence and risk factors for 30-day mortality–a retrospective cohort study
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
- Contribution to journal › Scientific review
-
Mark
Diagnostic and prognostic factors in patients with prostate cancer : a systematic review
- Contribution to journal › Scientific review
-
Mark
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
- Contribution to journal › Article
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
- Contribution to journal › Debate/Note/Editorial
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
- Contribution to journal › Article
